Alibaba Cloud Digitalizes Sports Events with More AI Solutions
During Apsara Conference 2020, the digital technology and intelligence backbone of Alibaba Group, unveiled a series of artificial intelligence (AI) powered solutions which are set to transform and digitalize the way sports entertainment was traditionally organized, broadcast and consumed. The solutions are designed to bring spectators closer to the events’ center stage for more personalized and interactive engagement, while helping organizers and broadcasters operate more efficiently, effectively and securely.
Event organizers are set to benefit considerably from Alibaba Cloud’s Event Simulation Services (ESS). Running on cloud and powered by elastic compute, ESS can help organizers plan the layout of indoor venues virtually, optimizing the position of equipment and facilities, without having to move or commission a single piece of physical kit. With the ability to create a digital twin, ESS negates the time, expense and risk of physical tests and run-throughs, providing a comprehensive digital examination of a venue for all key stakeholders. When it comes to event broadcasting planning, ESS enables broadcasters to simulate and test different camera positions before installing camera tracks, thereby offering audiences the best point of view. Furthermore, ESS provides organizers with a wealth of insights for post-event analysis for more effective future planning.
For large-scale events, crowd management and access control could be time-consuming and cumbersome to coordinate. The typical paper-based accreditation system is not effective enough, especially at a time when venue coordinators are working hard to maintain social distancing measures.
Alibaba Cloud has developed a Digital Badge System which embeds access control and essential event information with digital accreditation. Developed to be simple to use, the digital badge system negates the need to print a paper ticket, not only being more environmentally friendly, but also reducing the risk of access pass counterfeiting. When using the digital badge, cards that carry important information such as maps, event times and organizer contact details, can be issued within seconds and on demand, removing the inventory problems often associated with paper-based systems. Card holders can also receive card expiration notices and other important notifications in real-time. In addition, event organizers have the option to embed health advisory information in the event of COVID-19 outbreaks.
Broadcasters and journalists are imperative in bringing the joy and excitement of sports stories to fans around the world. To improve their experience when attending press conferences, Alibaba Cloud has launchedPress Conference on Cloud to facilitate virtual media briefings using proven live and on-demand streaming technologies. The solution broadens the reach and increases efficiency for journalists, who do not need to be physically present in order to join press conferences, saving them valuable time in crafting news stories, as well as the hassles of travelling to different venues in gigantic sports parks. Furthermore, with Press Conference on Cloud, reporters may even choose to attend more than one briefing happening in different locations at the same time to maximise their efficiency and productivity.
To bring fans closer to sports events, Alibaba Cloud also launched Fan Video Hub to enable sports fans from all over the world to support their favourite teams and athletes more personally, regardless of their location. The AI-powered technology can act as an efficient aggregator, which is able to collect and filter real-time videos uploaded by fans from all over the world to a variety of social network platforms, before broadcasting them onto designated online platforms, or in venues where the event being enjoyed is going on. Organizers of sports events can initiate special projects, encouraging fans to create motivating and personalized videos that will eventually be displayed in sports stadiums.
“As a global leading cloud service provider, we are excited to see our mature technology innovations to be used to support the digital transformation of some of the largest international sports events,” said Selina Yuan, President of International Business, Alibaba Cloud Intelligence. “For example, with Alibaba Cloud’s trusted infrastructure and services, we are able to work with stadiums and event managers to create even more thrilling and immersive experiences for fans, wherever they’re based. More importantly, health and safety has to be front of mind at all venues and events, and our solutions help event organizers deliver on their post-pandemic responsibilities through reduced and unnecessary travel. We want to maximize the thrill of sporting achievements, while enabling event organizers to work safely and even more efficiently with fans and global broadcasters.”
Alibaba Cloud is committed to digitalizing sports events through helping broadcasters revolutionalize the experience. In September 2018, together with Olympic Broadcasting Services (OBS), Alibaba Cloud launched OBS cloud, which was developed to transform the process for bringing the Olympic Games to viewers. Alibaba Cloud is also the official cloud services partner of the International Olympic Committee.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (www.alibabacloud.com), the digital intelligence and technology backbone of Alibaba Group, is among the world’s top three IaaS providers, according to Gartner, and the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and government organisations. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.
+86 571 86561860
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ESMO 2020: Cabometyx ® (cabozantinib) in Combination With Opdivo ® (nivolumab) Demonstrates Significant Survival Benefits in Patients With Advanced Renal Cell Carcinoma in Pivotal Phase III CheckMate -9ER Trial19.9.2020 18:30:00 CEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the first presentation of results from the pivotal Phase III CheckMate -9ER trial, in which Cabometyx® (cabozantinib) in combination with Bristol Myers Squibb’s Opdivo® (nivolumab) demonstrated significant improvements across all efficacy endpoints, including overall survival (OS), in previously untreated advanced renal cell carcinoma (RCC).1 Cabometyx® in combination with Opdivo® reduced the risk of death by 40% versus sunitinib (HR: 0.60 [98.89% Confidence Interval [CI]: 0.40–0.89]; p= 0.0010; median OS not reached in either arm). In patients receiving Cabometyx® in combination with Opdivo®, median progression-free survival (PFS), the trial’s primary endpoint, was doubled compared to those receiving sunitinib alone: 16.6 months versus 8.3 months respectively (Hazard Ratio [HR]: 0.51 [95% CI 0.41–0.64], p < 0.0001). In addition, Cabometyx® in combination with Opdivo® demonstrated a superior objective response rate, wit
Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer at ESMO Virtual Congress18.9.2020 12:55:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the company is presenting data from its lung cancer portfolio at the virtual European Society for Medical Oncology (ESMO) conference. Notably, insights from sub-analyses of the Phase 3 ALTA 1L study reinforce both the compelling evidence of intracranial efficacy with ALUNBRIG® (brigatinib) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) as well as associated quality of life (QoL) data. Takeda is also featuring updated 10-month follow-up results from the Phase 1/2 trial of mobocertinib (TAK-788), demonstrating mobocertinib achieved a duration of response (DoR) of more than one year in the trial’s study population of patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic NSCLC (mNSCLC). “We’re pleased to present our ongoing research in lung cancer at this year’s virtual ESMO congress, including new
Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal18.9.2020 12:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced results from its Phase 2 POD1UM-202 trial evaluating retifanlimab, a PD-1 inhibitor, in previously treated patients with advanced squamous cell carcinoma of the anal canal (SCAC) who have progressed following standard platinum-based chemotherapy. The trial enrolled 94 patients, including those with well-controlled human immunodeficiency virus (HIV) infection (10%). Retifanlimab monotherapy resulted in a confirmed objective response rate (ORR) of 14% as determined by independent central review (ICR) using RECIST v1.1. Responses were observed regardless of PD-L1 status, presence of liver metastases, age or HIV+ status. Retifanlimab was generally well-tolerated with a safety profile as expected of a PD-1 inhibitor and no loss of HIV infection control. Key findings from POD1UM-202: N=94 ORR* (95% CI) 13.8% (7.6-22.5) Best OR*, n 1 CR 12 PR 33 SD DCR 48.9% DOR, median (95% CI), months 9.5 (5.6-NE) PFS, median (95% CI), months 2.3 (1.9-3.6) OS, median (95
Sigfox and Cube Infrastructure Managers Announce Major Partnership in IoT Infrastructure18.9.2020 09:30:00 CEST | Press release
Sigfox, the global 0G network1 and cloud provider for industrial data, is proud to announce a new strategic alliance with Cube Infrastructure Managers (Cube), through the sale of its German 0G network to Cube. Sigfox has grown its 0G IoT services by rolling out 0G networks across 72 countries and regions, which was largely achieved with partners called Sigfox Operators. These operators are the owners of the 0G networks, which they operate as exclusive connectivity providers of Sigfox IoT services, offering worldwide connectivity to customers. The sale of the German network to Cube will allow Sigfox to finance its continued innovation efforts in data value extraction and improvements in cloud algorithms to reduce energy consumption and allow the implementation of even more cost-effective devices and sensors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200918005116/en/ Cube Infrastructure Managers, the European infrastructu
Sensorion successfully raises approximately €31 (US$ 36.5) million in an oversubscribed private placement to US and European investors18.9.2020 08:00:00 CEST | Press release
Regulatory News: Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This press release is not intended as an offer and is for informational purpose only Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN – the “Company”) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders announces today the success of its previously announced capital increase. The Company has placed 18,236,000 new ordinary shares with a nominal value of €0.10 each (the “New Shares”), for total gross proceeds of approximately € 31 million by means of an accelerated bookbuild offering to the benefit of categories of persons (the “Reserved Offering”). The issue price of the New Shares is €1.70 per share, representing a 3.5% discount to the weighted average share price on the day preceding the date on which the issuance price
Vifor Pharma Group Announces Successful Sale of OM Pharma18.9.2020 07:00:00 CEST | Press release
Regulatory News: Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include: A purchase consideration of MCHF 435 for 100% of the share capital An earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity to be determined before the end of 2027 upon a trade sale, IPO or EBITDA multiple This earn out together with the purchase consideration could result in a total transaction value exceeding MCHF 500. The deal is expected to close within 30 days. OM Pharma is a Geneva-based company mainly active in the field of microbial derived immunotherapeutics and has developed strongly outside the core strategy of Vifor Pharma over the past few years. Optimus Holding Ltd. is a Swiss Group, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a Turkey-based pharmaceutical company operating in 12 countries a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom